Fiche du document
19 mai 2021
- doi: 10.53738/REVMED.2021.17.739.0957
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.739.0957
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/34009753
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_80DEB9D1E4CC9
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
GestationCiter ce document
M. Schnetz et al., « Cancer du sein chez la femme en [Breast cancer during pregnancy] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.739.0957
Métriques
Partage / Export
Résumé
The management of patients with breast cancer during their pregnancy is challenging. A good coordination is required between the oncology and obstetrics teams in order to ensure appropriate care, while providing a reassuring environment during this stressful period. Most often, the pregnancy can continue without delaying the initiation of oncological treatments, offering a prognosis similar to non-pregnant women. Surgery and chemotherapy can be done during pregnancy, unlike endocrine therapy, radiotherapy and antibody treatments which can only be given postpartum. While some imaging techniques are compatible, others require special measures or are contraindicated. We discuss these points in the context of a clinical situation.